PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Esketamine Timing Matters: Pre-Extubation Dosing Cuts Emergence Agitation After Nasal Surgery

esketamineS-ketamineNMDA antagonistemergence agitationnasal endoscopic surgerygeneral anesthesiarandomized controlled trialtiming of administrationperioperative pharmacologysubanesthetic dose Psychiatry / Psychopharmacology

Background Information

Esketamine timing crucial for reducing anesthesia-related agitation.

Emergence agitation (EA) is common after anesthesia, impacting recovery quality. Administration of esketamine 20 minutes before surgery reduced EA incidence to 9.7% compared to 40.6% with placebo. Single-center findings suggest timing of esketamine administration is crucial, but require multicenter validation. Administering esketamine before surgery's end can significantly reduce emergence agitation.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Wen X, Sun W, Chen W, Guo L, Zhang Y, Lv S, Liu Y, Qiu Z

Citation: Wen X, Sun W, Chen W, et al. Impact of administration timing of subanesthetic doses of esketamine on emergence agitation in patients undergoing nasal endoscopic surgery: a randomized controlled trial. Frontiers in medicine. 2026;13:1978040. doi:10.3389/fmed.2026.1978040

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.